Skip to content

13F-HR filed by Merck & Co., Inc.

Merck & Co., Inc. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 21:12:13 UTC, with 13 holding rows worth $820,348,090.

Accession
0000310158-26-000249
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 13 entries on the cover page, a total value of $820,348,090 stated on the cover page (in dollars after the unit check, H1), rows summing to $820,348,090 with VALUE read as dollars as filed, 13F file number 028-25193. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MODERNA INC60770K107COM2,308,190$444,488,148dollars as filed
PERSONALIS INC71535D106COMMON STOCK14,044,943$228,651,672dollars as filed
KYMERA THERAPEUTICS INC501575104COM772,165$86,320,325dollars as filed
AKTIS ONCOLOGY INC01021M104COMMON STOCK952,844$18,551,873dollars as filed
EIKON THERAPEUTICS INC282564103COMMON STOCK1,666,666$13,399,995dollars as filed
ENTRADA THERAPEUTICS INC COM29384C108Stock1,739,768$11,047,527dollars as filed
ALECTOR INC014442107COMMON STOCK3,545,719$6,559,581dollars as filed
SUTRO BIOPHARMA INC869367201COMMON STOCK272,351$4,387,575dollars as filed
EVAXION AS29970R303SPONSORED ADS1,214,126$3,982,333dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM93,414$1,923,394dollars as filed
XILIO THERAPEUTICS INC98422T209COM105,982$959,137dollars as filed
TUHURA BIOSCIENCES INC898920103COM19,445$40,834dollars as filed
NEUPHORIA THERAPEUTICS INC64136E102COM10,027$35,696dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000310158-26-000249this filing2026-11-13